Abstract
Identification of high-risk atherosclerotic lesions prone to rupture and thrombosis may greatly decrease the morbidity and mortality associated with atherosclerosis. High-resolution magnetic resonance imaging (MRI) has recently emerged as one of the most promising techniques for the noninvasive study of atherothrombotic disease, as it can characterize plaque composition and monitor its progression. The development of MRI contrast agents that specifically target components of the atherosclerotic plaque may enable non-invasive detection of high-risk lesions. This review discusses the use of high-resolution MRI for plaque detection and characterization and the potentials of Molecular Imaging using a variety of molecules present in atherosclerotic plaques that may serve as targets for specific contrast agents to allow the identification of high-risk atherosclerotic lesions invivo. Ultimately, such agents may enable treatment of high-risk patients prior to lesion progression and occurrence of complications.
Keywords: Atherosclerosis, magnetic resonance imaging, coronary artery disease
Current Molecular Medicine
Title: Plaque Imaging and Characterization Using Magnetic Resonance Imaging: Towards Molecular Assessment
Volume: 6 Issue: 5
Author(s): Marc Sirol, Valentin Fuster and Zahi A. Fayad
Affiliation:
Keywords: Atherosclerosis, magnetic resonance imaging, coronary artery disease
Abstract: Identification of high-risk atherosclerotic lesions prone to rupture and thrombosis may greatly decrease the morbidity and mortality associated with atherosclerosis. High-resolution magnetic resonance imaging (MRI) has recently emerged as one of the most promising techniques for the noninvasive study of atherothrombotic disease, as it can characterize plaque composition and monitor its progression. The development of MRI contrast agents that specifically target components of the atherosclerotic plaque may enable non-invasive detection of high-risk lesions. This review discusses the use of high-resolution MRI for plaque detection and characterization and the potentials of Molecular Imaging using a variety of molecules present in atherosclerotic plaques that may serve as targets for specific contrast agents to allow the identification of high-risk atherosclerotic lesions invivo. Ultimately, such agents may enable treatment of high-risk patients prior to lesion progression and occurrence of complications.
Export Options
About this article
Cite this article as:
Sirol Marc, Fuster Valentin and Fayad A. Zahi, Plaque Imaging and Characterization Using Magnetic Resonance Imaging: Towards Molecular Assessment, Current Molecular Medicine 2006; 6 (5) . https://dx.doi.org/10.2174/156652406778018617
DOI https://dx.doi.org/10.2174/156652406778018617 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nutrition and Bone Health: Its Relationship to Osteoporosis
Current Nutrition & Food Science Cytotoxic Properties of Clofibrate and other Peroxisome Proliferators: Relevance to Cancer Progression
Current Medicinal Chemistry Gesture Interaction for Coronary Heart Diseases Based on Wavelet Transform and Semi-Continuous Hidden Markov Model in Augmented Reality
Recent Advances in Electrical & Electronic Engineering Editorial (Thematic Issue: Oxidative Stress as a Pharmacological Target for Medicinal Chemistry: Synthesis and Evaluation of Compounds with Redox Activity - Part 3)
Current Topics in Medicinal Chemistry Regulation of Inflammation and Myocardial Fibrosis in Experimental Autoimmune Myocarditis
Inflammation & Allergy - Drug Targets (Discontinued) RETRACTED: Human Suicide, Modern Diagnosis Assistance and Magic Bullet Discovery
Central Nervous System Agents in Medicinal Chemistry Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Treatment of Hypertension: Should they be Used Together?
Current Vascular Pharmacology Editorial (Thematic Issue: Current Research, Knowledge and Controversies on High Density Lipoprotein)
Current Medicinal Chemistry Activating Mutations of ESR1, BRCA1 and CYP19 Aromatase Genes Confer Tumor Response in Breast Cancers Treated with Antiestrogens
Recent Patents on Anti-Cancer Drug Discovery Monitoring Therapeutic Anticoagulation with Low Molecular Weight Heparins: Is it Useful or Misleading?
Cardiovascular & Hematological Agents in Medicinal Chemistry Management of Osteoporosis: Seeing the Future
Medicinal Chemistry Reviews - Online (Discontinued) Protein-Protein Interaction (PPI) Network: Recent Advances in Drug Discovery
Current Drug Metabolism Patent Selections
Recent Patents on Biomedical Engineering (Discontinued) Development and Performance Research of New Small Displacement Pump with Solid Plunger and Non-coaxial Delivery Valve
Recent Patents on Engineering Therapeutic Value of Statins for Vascular Remodeling
Current Vascular Pharmacology Type 1 11 β-hydroxysteroid Dehydrogenase as Universal Drug Target in Metabolic Diseases?
Endocrine, Metabolic & Immune Disorders - Drug Targets Potential of Photobiomodulation to Induce Differentiation of Adipose- Derived Mesenchymal Stem Cells into Neural Cells
Current Stem Cell Research & Therapy Effects of Estrogen in Gender-dependent Fetal Programming of Adult Cardiovascular Dysfunction
Current Vascular Pharmacology Meet Our Editorial Board Member
Current Vascular Pharmacology NLRP3 Inflammasome Activation Leads to Epileptic Neuronal Apoptosis
Current Neurovascular Research